Proteon Therapeutics, Inc.
Life Sciences Drug DevelopmentWaltham, MA
Proteon Therapeutics, Inc., is a privately held biotechnology company developing novel, first-in-class pharmaceuticals to address the critical, rapidly expanding medical needs of patients with renal and vascular diseases. The company is leveraging a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics' first drug candidate (PRT-201) improves blood flow during vascular surgery procedures by providing rapid, permanent, and localized vasodilation.